Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 48 min ago
Peer-reviewedCC BY 4.0Scientific Reports

Heart rate response and clinical determinants of Glittre activities of daily living test performance in pediatrics with cystic fibrosis

Abstract

The Pediatric Glittre Activities of Daily Living Test (TGlittre-P) is a field test designed to assess the functional performance of activities of daily living (ADL) in pediatric patients with cystic fibrosis (CF). However, the effects of TGlittre-P on heart rate response and the clinical determinants of test performance in this population remain insufficiently understood. To compare the heart rate response elicited by the TGlittre-P and the six-minute walk test (6MWT), and to identify pulmonary and extrapulmonary factors associated with TGlittre-P performance in pediatric patients with CF. Fifty-four pediatric patients with CF (mean age = 14.46 ± 2.16 years, 31 females and 23 males) were included in this cross-sectional study. ADL performance was assessed using the TGlittre-P, and functional capacity was assessed using the 6MWT. Pulmonary function, including forced expiratory volume in one second (FEV₁) and forced vital capacity (FVC), maximal inspiratory and expiratory pressure (MIP and MEP, respectively), handgrip strength (HGS %) and quadriceps muscle strength (QMS %) were measured. A multiple linear regression analysis model was used to determine independent predictors of TGlittre-P performance. The mean TGlittre-P duration was 2.00 ± 0.53 min. There was agreement between recorded peak heart rate (HRpeak) responses during the TGlittre-P and 6MWT (mean difference: -2.33%, with limits of agreement ranging from − 41.19 to 36.52). HRpeak (bpm), HRpeak (% predicted HRmax), and pre-to-post changes in systolic and diastolic blood pressure (mmHg), oxygen saturation (%), and perceived effort were not different between TGlittre-P and 6MWT (p > 0.05). TGlittre-P duration (min) correlated with 6MWT distance (m), FEV1 (%), FEV1z-score, FVC (%), FVC z-score, MIP (cmH2O), MEP (cmH2O), HGS (%) and QMS (%) (p < 0.05). The FEV1 z-score, height z-score and sex were predictors for TGlittre-P duration (min) [Adjusted R2 = 0.402, F(3, 53) = 11.755, p < 0.001, constant = 1.625]. No significant differences were observed in the measured heart rate response between the TGlittre-P and 6MWT. TGlittre-P performance is strongly associated with pulmonary function and respiratory and peripheral muscle strength. Airway obstruction was the strongest predictor of TGlittre-P performance in this population.

Related

  1. Genomic and clinical determinants of response to Azacitidine plus venetoclax in acute myeloid leukemia: Results from the HM-SCREEN-Japan 02 study
    Tomoaki Ueda, Kentaro Fukushima, Sunggi Chi +12
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPhysiologyPLOS
  2. Clinical and laboratory determinants of treatment response and rifampicin resistance among Xpert MTB/RIF-confirmed extrapulmonary tuberculosis patients: A prospective study from Central India
    Gautam Bhagwat, Mala Kanthali, Swati Chauhan +3
    PLOS OnePeer-reviewedCC BYFull textGeneral biochemistryCell biologyPLOSEurope PMCPMC
  3. Functional independence and sociodemographic determinants of activities of daily living among patients with thalassemia in Southern Iraq: a cross-sectional analytical study
    Alaa Muhaibes Tuama, Ali Faris Abdul Hussein, Laith salah hashim +4
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textHuman geneticsCrossref
  4. Clinical and genomic determinants of extraordinary response and resistance to androgen receptor pathway inhibitors in men with metastatic androgen pathway modulator sensitive (APMS) prostate cancer
    Jane McKenzie, Lauren Howard, Joseph J. Park +13
    Prostate Cancer and Prostatic DiseasesPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  5. Perceived must see pediatric conditions vs. actual clinical exposure during an undergraduate pediatrics clerkship.
    Hamed Al Ahbabi, Omar Tafech, Hassan Ballas +9
    Frontiers in medicinePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
BibTeX
@article{bozdemir2026heart,
  title = {{Heart rate response and clinical determinants of Glittre activities of daily living test performance in pediatrics with cystic fibrosis}},
  author = {Cemile Bozdemir and Elif Kocaaga and Haluk Tekerlek and Deniz Inal-Ince and Hulya Arikan and Melda Saglam and Naciye Vardar-Yagli and Ebru Calik and Ugur Ozcelik and Deniz Dogru and Nural Kiper and Ebru Gunes Yalcin},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-74157-4},
  url = {https://www.nature.com/articles/s41598-026-74157-4},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Heart rate response and clinical determinants of Glittre activities of daily living test performance in pediatrics with cystic fibrosis
AU  - Cemile Bozdemir
AU  - Elif Kocaaga
AU  - Haluk Tekerlek
AU  - Deniz Inal-Ince
AU  - Hulya Arikan
AU  - Melda Saglam
AU  - Naciye Vardar-Yagli
AU  - Ebru Calik
AU  - Ugur Ozcelik
AU  - Deniz Dogru
AU  - Nural Kiper
AU  - Ebru Gunes Yalcin
PY  - 2026
DA  - 2026/10/03
JO  - Scientific Reports
DO  - 10.1038/s41598-026-74157-4
UR  - https://www.nature.com/articles/s41598-026-74157-4
AB  - The Pediatric Glittre Activities of Daily Living Test (TGlittre-P) is a field test designed to assess the functional performance of activities of daily living (ADL) in pediatric patients with cystic fibrosis (CF). However, the effects of TGlittre-P on heart rate response and the clinical determinants of test performance in this population remain insufficiently understood. To compare the heart rate response elicited by the TGlittre-P and the six-minute walk test (6MWT), and to identify pulmonary and extrapulmonary factors associated with TGlittre-P performance in pediatric patients with CF. Fifty-four pediatric patients with CF (mean age = 14.46 ± 2.16 years, 31 females and 23 males) were included in this cross-sectional study. ADL performance was assessed using the TGlittre-P, and functional capacity was assessed using the 6MWT. Pulmonary function, including forced expiratory volume in one second (FEV₁) and forced vital capacity (FVC), maximal inspiratory and expiratory pressure (MIP and MEP, respectively), handgrip strength (HGS %) and quadriceps muscle strength (QMS %) were measured. A multiple linear regression analysis model was used to determine independent predictors of TGlittre-P performance. The mean TGlittre-P duration was 2.00 ± 0.53 min. There was agreement between recorded peak heart rate (HRpeak) responses during the TGlittre-P and 6MWT (mean difference: -2.33%, with limits of agreement ranging from − 41.19 to 36.52). HRpeak (bpm), HRpeak (% predicted HRmax), and pre-to-post changes in systolic and diastolic blood pressure (mmHg), oxygen saturation (%), and perceived effort were not different between TGlittre-P and 6MWT (p > 0.05). TGlittre-P duration (min) correlated with 6MWT distance (m), FEV1 (%), FEV1z-score, FVC (%), FVC z-score, MIP (cmH2O), MEP (cmH2O), HGS (%) and QMS (%) (p < 0.05). The FEV1 z-score, height z-score and sex were predictors for TGlittre-P duration (min) [Adjusted R2 = 0.402, F(3, 53) = 11.755, p < 0.001, constant = 1.625]. No significant differences were observed in the measured heart rate response between the TGlittre-P and 6MWT. TGlittre-P performance is strongly associated with pulmonary function and respiratory and peripheral muscle strength. Airway obstruction was the strongest predictor of TGlittre-P performance in this population.
SN  - 2045-2322
ER  -